The FDA marketing approval for 7 Vuse e-cigarettes is a major regulatory achievement for R.J. Reynolds, which is a subsidiary of British American Tobacco (BTI). This approval could enhance BTI's competitive edge in the e-cigarette market, likely leading to a positive short-term impact on its stock price.